Publications by authors named "Doris Ponce"

Claim this Profile
R
Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease.
Gagan Raju, Moneeza Walji, David Nemirovsky, Sean Devlin, Ilan Goldstein, Doris M Ponce

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study.
Michael Scordo, Miguel-Angel Perales, Audrey Mauguen, Andrew Lin, Binni Kunvarjee, Doris M Ponce

Lancet Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients.
Mark Y Jeng, Phillip Wong, Jessica R Flynn, Erika Ritter, Caleb Ho, Doris R Ponce

J Geriatr Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohort.
Shlomo Elias, Samantha Brown, Ogechukwu Egini, Moneeza Walji, Sylvester Homsy, Doris M Ponce

Blood Cancer J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative Analysis.
Mohammad Alhomoud, Glenn Heller, Christina Cho, Joshua A Fein, Parastoo B Dahi, Doris M Ponce

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation.
Ioannis Politikos, Samantha Brown, Joshua A Fein, Stephen Eng, Kristian Casem, Doris M Ponce

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transplant Pain and Paralysis: Neurologic Amyotrophy as an Atypical Cause of Shoulder Dysfunction Following Hematopoietic Stem Cell Transplant.
Franchesca König, Chanel Davidoff, Katarzyna Ibanez, Sinchun Hwang, Ilan Goldstein, Doris M Ponce

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis.
Joseph Pidala, Jongphil Kim, Denise Kalos, Corey Cutler, Zachariah DeFilipp, Doris Ponce

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing a Graft-Versus-Host Disease (GVHD)-Focused Multidisciplinary Telehealth Clinic.
Andrew C Harris, Alina Markova, Sean Devlin, Amandeep Singh, Pamela Susman, Doris M Ponce

Transplant Cell Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scalable log-ratio lasso regression for enhanced microbial feature selection with FLORAL.
Teng Fei, Tyler Funnell, Nicholas R Waters, Sandeep S Raj, Mirae Baichoo, Doris M Ponce

Cell Rep Methods· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies.
Melissa Krystel-Whittemore, Kseniya Petrova-Drus, Ryan N Ptashkin, Mark D Ewalt, JinJuan Yao, Doris Ponce

Haematologica· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates in chronic graft-versus-host disease: novel treatments and best practices in the current era.
Grashma Vadakkel, Stephen Eng, Anthony Proli, Doris M Ponce

Bone Marrow Transplant· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease.
Eiko Hayase, Tomo Hayase, Akash Mukherjee, Stuart C Stinson, Mohamed A Jamal, Doris M Ponce

Cell Host Microbe· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Karthik Nath, Kristen Peterson, Samantha Brown, Sean Devlin, Natasia Rodriguez, Doris Ponce

Transplant Cell Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Feature Selection for Microbiome Data using FLORAL: Scalable Log-ratio Lasso Regression.
Teng Fei, Tyler Funnell, Nicholas R Waters, Sandeep S Raj, Keimya Sadeghi, Doris M Ponce

bioRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation.
Shlomo Elias, Samantha Brown, Sean M Devlin, Juliet N Barker, Christina Cho, Doris M Ponce

Br J Haematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia.
Karthik Nath, Jasme Lee, Theresa A Elko, Lauren Levy, Elaina Preston, Doris M Ponce

Am J Hematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide-based transplant.
Andrew Lin, Samantha Brown, Stephanie Chinapen, Yeon Joo Lee, Susan K Seo, Doris M Ponce

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease.
Monzr M Al Malki, Kaitlyn London, Janna Baez, Yu Akahoshi, William J Hogan, Doris M Ponce

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia.
Warren B Fingrut, Boglarka Gyurkocza, Jessica Flynn, Eric Davis, Sean Devlin, Doris Ponce

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse.
Susan DeWolf, Yuval Elhanati, Katherine Nichols, Nicholas R Waters, Chi L Nguyen, Doris M Ponce

Sci Transl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation.
Miriam Sanchez-Escamilla, Jessica Flynn, Sean Devlin, Molly Maloy, Samira A Fatmi, Doris Ponce

Bone Marrow Transplant· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract.
Doris M Ponce, Amin M Alousi, Ryotaro Nakamura, John Slingerland, Marco Calafiore

Blood· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the microbiome to improve outcomes in stem cell transplant.
Doris M Ponce

Clin Adv Hematol Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era.
John L Vaughn, Samantha Brown, Esperanza B Papadopoulos, Ann A Jakubowski, Roni Tamari, Doris M Ponce

Bone Marrow Transplant· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis